Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

US12071404B2 · kind B2 · utility

Assignee

• UCB Pharma GMBH · DE

Inventors

• Christa E. Mueller · Bonn, DE
• Cecile Pegurier · Uccle - Ukkel, BE
• Michael Deligny · Brussels, BE
• Ali El-Tayeb · Bonn, DE
• Joerg Hockemeyer · Bonn, DE
• Marie Ledecq · Éghezée, BE
• Joel Mercier · Soye, BE
• Laurent Provins · Soignies, BE
• Nader M. BOSHTA · Bonn, DE
• Sanjay BHATTARAI · Lawrence, US
• Vigneshwaran Namasivayam · Bonn, DE
• Mario FUNKE · Friedrichshafen, DE
• Lukas SCHWACH · Bonn, DE
• Sabrina GOLLOS
• Daniel Von Laufenberg · Siegburg, DE
• Anaïs BARRÉ · Montargis, FR

Key dates

• Filing date: Oct 20, 2021
• Grant date: Aug 27, 2024
• Expiry date: Oct 20, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D493/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.